Results 141 to 150 of about 5,756 (158)

Ivabradine

2010
openaire   +1 more source

Ivabradine for rate control in atrial fibrillation

International Journal of Cardiology, 2015
Sabrina Oebel
exaly  

Duration of Chronic Heart Failure Affects Outcomes with Preserved Effects of Heart Rate Reduction with Ivabradine: Findings from SHIFT

European Journal of Heart Failure, 2018
Christoph Maack
exaly  

A pharmacokinetic simulation model for ivabradine in healthy volunteers

European Journal of Pharmaceutical Sciences, 2000
Stephen Duffull, Pascal Girard, Leon Aarons   +2 more
exaly  

Effects of Ivabradine on the Pulmonary Vein Electrical Activity and Modulation of Pacemaker Currents and Calcium Homeostasis

Journal of Cardiovascular Electrophysiology, 2012
, Kazuyoshi Suenari
exaly  

Pharmacokinetic interaction between ivabradine and carbamazepine in healthy volunteers

Journal of Clinical Pharmacy and Therapeutics, 2011
Laurian Vlase, Dana Muntean, Sorin Emilian Leucuta   +2 more
exaly  

Potential New Indication for Ivabradine: Treatment of a Patient with Congenital Junctional Ectopic Tachycardia

Journal of Cardiovascular Electrophysiology, 2013

exaly  

Effects on Outcomes of Heart Rate Reduction by Ivabradine in Patients With Congestive Heart Failure: Is There an Influence of Beta-Blocker Dose?

Journal of the American College of Cardiology, 2012
Ian Ford
exaly  

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

Lancet, The, 2010
Ian Ford
exaly  

Ivabradine prolongs phase 3 of cardiac repolarization and blocks the hERG1 (KCNH2) current over a concentration-range overlapping with that required to block HCN4

Journal of Molecular and Cellular Cardiology, 2015
Sergei Noskov, , Yibo Wang
exaly